These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32207675)

  • 1. Combining Cognitive Markers to Identify Individuals at Increased Dementia Risk: Influence of Modifying Factors and Time to Diagnosis.
    Payton NM; Rizzuto D; Fratiglioni L; Kivipelto M; Bäckman L; Laukka EJ
    J Int Neuropsychol Soc; 2020 Sep; 26(8):785-797. PubMed ID: 32207675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Cognitive, Genetic, and Structural Neuroimaging Markers to Identify Individuals with Increased Dementia Risk.
    Payton NM; Kalpouzos G; Rizzuto D; Fratiglioni L; Kivipelto M; Bäckman L; Laukka EJ
    J Alzheimers Dis; 2018; 64(2):533-542. PubMed ID: 29889068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
    J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of cognitive aging profiles over 15 years: A longitudinal population-based study.
    Ekström I; Josefsson M; Bäckman L; Laukka EJ
    Psychol Aging; 2024 Aug; 39(5):467-483. PubMed ID: 38753406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
    Mazzeo S; Santangelo R; Bernasconi MP; Cecchetti G; Fiorino A; Pinto P; Passerini G; Falautano M; Comi G; Magnani G
    J Alzheimers Dis; 2016 Oct; 54(4):1495-1508. PubMed ID: 27589522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease.
    Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Amberla K; Axelman K; Basun H; Kinhult-Ståhlbom A; Lilius L; Remes A; Wahlund LO; Viitanen M; Lannfelt L; Graff C
    J Int Neuropsychol Soc; 2017 Mar; 23(3):195-203. PubMed ID: 28079014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study.
    Palmer K; Bäckman L; Winblad B; Fratiglioni L
    BMJ; 2003 Feb; 326(7383):245. PubMed ID: 12560271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semantic item-level metrics relate to future memory decline beyond existing cognitive tests in older adults without dementia.
    Vonk JMJ; Geerlings MI; Avila-Rieger JF; Qian CL; Schupf N; Mayeux R; Brickman AM; Manly JJ
    Psychol Aging; 2023 Aug; 38(5):443-454. PubMed ID: 37199965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive deficits in preclinical Alzheimer's disease and vascular dementia: patterns of findings from the Kungsholmen Project.
    Bäckman L; Small BJ
    Physiol Behav; 2007 Sep; 92(1-2):80-6. PubMed ID: 17573076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The trajectory of cognitive decline in the pre-dementia phase in memory clinic visitors: findings from the 4C-MCI study.
    Hamel R; Köhler S; Sistermans N; Koene T; Pijnenburg Y; van der Flier W; Scheltens P; Aalten P; Verhey F; Visser PJ; Ramakers I
    Psychol Med; 2015 May; 45(7):1509-19. PubMed ID: 25407094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined genetic influences on episodic memory decline in older adults without dementia.
    Laukka EJ; Köhncke Y; Papenberg G; Fratiglioni L; Bäckman L
    Neuropsychology; 2020 Sep; 34(6):654-666. PubMed ID: 32352830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological Measures that Predict Progression from Mild Cognitive Impairment to Alzheimer's type dementia in Older Adults: a Systematic Review and Meta-Analysis.
    Belleville S; Fouquet C; Hudon C; Zomahoun HTV; Croteau J;
    Neuropsychol Rev; 2017 Dec; 27(4):328-353. PubMed ID: 29019061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).
    Marra C; Gainotti G; Fadda L; Perri R; Lacidogna G; Scaricamazza E; Piccininni C; Quaranta D
    J Alzheimers Dis; 2016; 50(1):61-70. PubMed ID: 26639965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust norms for neuropsychological tests of verbal episodic memory in Australian women.
    Goodwill AM; Campbell S; Henderson VW; Gorelik A; Dennerstein L; McClung M; Szoeke C
    Neuropsychology; 2019 May; 33(4):581-595. PubMed ID: 30829514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episodic-Memory Performance in Machine Learning Modeling for Predicting Cognitive Health Status Classification.
    Bergeron MF; Landset S; Tarpin-Bernard F; Ashford CB; Khoshgoftaar TM; Ashford JW
    J Alzheimers Dis; 2019; 70(1):277-286. PubMed ID: 31177223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.